A client will be self-administering desmopressin (DDAVP) ...

[Tazate]

A client will be self-administering desmopressin (DDAVP) intranasally at home after discharge. What should the nurse instruct the client regarding the administration of this medication?
 
  Standard Text: Select all that apply.
  1. Direct the nasal spray high into the nasal cavity.
  2. Shake the medication before use.
  3. Store the medication at room temperature.
  4. Warm the solution in the microwave before use.
  5. Discard the solution if any particles are present in the solution.

Question 2

The nurse is concerned that a client prescribed octreotide (Sandostatin) is at risk for drug interactions because the client is currently prescribed which medications?
 
  Standard Text: Select all that apply.
  1. Antidiabetic agent
  2. Beta blocker
  3. Calcium channel blocker
  4. Antidiarrheal
  5. Antibiotics

[mirabriestensky]

Answer to Question 1

Correct Answer: 1,3,5
Rationale 1: The nurse should instruct the client to direct the nasal spray high into the nasal cavity.
Rationale 2: The nurse should instruct the client to not shake a nasal spray before use.
Rationale 3: The nurse should instruct the client to store the medication at room temperature.
Rationale 4: The nurse should instruct the client to avoid excessive heating of this medication.
Rationale 5: The nurse should instruct the client to discard any solutions with particulate matter present.
Global Rationale: The nurse should instruct the client to direct the nasal spray high into the nasal cavity and not to shake the canister prior to use. The medication should not be exposed to excessive heat and can be stored at room temperature. Any solutions with particulate matter should be discarded.

Answer to Question 2

Correct Answer: 1,2,3,4
Rationale 1: Concurrent administration with antidiabetic agents or insulin can produce hypoglycemia.
Rationale 2: Concurrent administration with a beta blocker can cause additive bradycardia.
Rationale 3: Concurrent administration with a calcium channel blocker can cause additive bradycardia.
Rationale 4: Concurrent administration with an antidiarrheal can lead to severe constipation, intestinal obstruction, or paralytic ileus.
Rationale 5: This medication does not interact with antibiotics.
Global Rationale: Concurrent administration with antidiabetic agents or insulin can produce hypoglycemia. Concurrent administration with a beta blocker or calcium channel blocker can cause additive bradycardia. Concurrent administration with an antidiarrheal can lead to severe constipation, intestinal obstruction, or paralytic ileus. This medication does not interact with antibiotics.

[Tazate]

TY

[mirabriestensky]

You're welcome